Cell experiments were performed using two human breast cancer cell lines (MDA-MB-231 and MDA-MB-436) (ATCC) and one human lung cancer cell line (A549) (ATCC). Cell lines were authenticated using STR profiling. Briefly, MDA-MB-231 and MDA-MB-436 cells were grown at 37 °C and 5% CO2 in high glucose (4.5 g/L) DMEM GlutaMax (Life Technologies) supplemented with 10% (v/v) foetal bovine serum (FBS), 1× penicillin-streptomycin, 1× non-essential amino acids, and 20 mM pH 7.3 HEPES buffer solution. A549 cells were grown at 37 °C and 5% CO2 in RPMI 1640 (Life Technologies) supplemented with 10% (v/v) FBS, 1× penicillin-streptomycin, 1× non-essential amino acids, and 20 mM pH 7.3 HEPES buffer solution. SW1222 human colon rectal cancer cells (ATCC) used for in vivo experiments were grown at 37 °C and 5% CO2 in DMEM (Life Technologies), supplemented with 10% (v/v) FBS and 1× penicillin-streptomycin.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.